A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to investigate the
pharmacokinetic (the rate at which the body eliminates the trial drug) and pharmacodynamic
(the effect of the trial drug on the body) profiles of NN1218 in comparison with insulin
aspart.